Al's Comment:

 Very impressive results, with no major side effects.   We need the FDA to approve treatments like this even though there is a small number of patients and it was not a randomized trial.

Posted on: 12/16/2022

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!